n.rowntree

TL3 Regular · Bucharest, RO

Wiki editor. Small, frequent, well-annotated edits.

Joined 15 August 2024 · last posted 5d · groups: wiki-editors

132 posts, newest first. Showing up to 150.

Prior authorisation: what the criteria usually require — a second dataset Replied, post #57 · Access › Insurance & coverage · 22 Jul 2026 · 1 like Same experience here, different supplier, so it is at least not unique to one of them.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #143 · Sourcing › Logistics · 22 Jul 2026 · 0 likes Confirming post #142 from a second method, which matters more than confirming it from a second person. My position on Regional warehouse stock versus direct is current…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #48 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 23 likes On Detection wavelength I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
Insurance and replacement policies, compared Replied, post #91 · Sourcing › Logistics · 15 Jul 2026 · 10 likes Helpful, and short, which on this subject is harder than long.
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #13 · Compounds › Tirzepatide · 14 Jul 2026 · 2 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Tirzepatide storage and stability looks different depending on whether you are…
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #6 · Practice › Administration · 11 Jul 2026 · 24 likes This is the sort of exchange that makes the archive worth searching.
Second pass at: Absence of evidence and evidence of absence Replied, post #42 · Research Methods › Statistics · 11 Jul 2026 · 11 likes Good question, well framed, and I would like to see it answered properly.
What a certificate commits its issuer to Replied, post #11 · Analytics › COA interpretation · 10 Jul 2026 · 3 likes Residual solvent screening is not standard on these documents and its presence is a signal about the manufacturer's own systems rather than about the vial. That is all…
Prescription portability between countries Replied, post #87 · Access › International · 4 Jul 2026 · 0 likes I read post #85 twice before replying, because I had assumed the opposite. Compounding in different countries: some countries allow pharmacy compounding under defined…
What a certificate commits its issuer to — the long version Replied, post #20 · Analytics › COA interpretation · 3 Jul 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Pages past their review date, listed — does this still hold? Replied, post #34 · Meta › Wiki maintenance · 2 Jul 2026 · 20 likes Building on post #33 rather than restating it. Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is…
The anatomy of a question that gets answered within an hour Replied, post #95 · Start Here › How to Ask · 30 Jun 2026 · 26 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I am aware this is the third time this…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #80 · Practice › Storage & stability · 28 Jun 2026 · 9 likes Post #79 is right about the mechanism and I think understates the practical bit. A note on scope: what I am saying about peptide applies to the case in the first post…
What a reversed-phase purity number actually is Replied, post #9 · Analytics › HPLC & UHPLC · 28 Jun 2026 · 23 likes Thank you — that answers what I came here to find out.
Hair shedding at month three: mechanism and time course — the long version Replied, post #36 · Practice › Side effects · 28 Jun 2026 · 0 likes Before the thread moves on from Hair shedding — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
Tracking a shortage from primary sources rather than rumour Replied, post #70 · Access › Shortages · 26 Jun 2026 · 0 likes Taking post #67 at face value and following it one step further. Regional differences during a shortage are large, and a supply position in one country says nothing…
Pooling trials with different estimands Replied, post #34 · Evidence › Meta-analyses · 19 Jun 2026 · 0 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. Take the reasoning and…
What I would want from a home test that does not exist yet Replied, post #14 · Analytics › Home & field testing · 19 Jun 2026 · 0 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #82 · Evidence › Preprints · 18 Jun 2026 · 27 likes Post #78 put the caveat in the right place and I want to underline it. Author track record is a weak signal and it is a signal. A group that has published carefully for…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #3 · Compounds › Retatrutide · 17 Jun 2026 · 0 likes Practical experience of retatrutide discussion, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make…
Pooling trials with different estimands Replied, post #23 · Evidence › Meta-analyses · 13 Jun 2026 · 20 likes Confirming post #20 from a second method, which matters more than confirming it from a second person. Pooled estimates and heterogeneity: when trials differ in…
Reading a home test result without over-claiming Replied, post #78 · Analytics › Home & field testing · 13 Jun 2026 · 0 likes Answering the question post #76 raises rather than the one it answers. Reading a home test result: I have looked for the primary source twice and failed twice. Either…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #25 · Practice › Reconstitution · 9 Jun 2026 · 0 likes Reconstituting a multi-strength kit has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Does dual agonism explain the effect size, or is it dose? Replied, post #22 · Compounds › Tirzepatide · 7 Jun 2026 · 1 like Reporting rather than recommending, on dual agonism. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #19 · Research Methods › N-of-1 designs · 22 May 2026 · 3 likes A washout period between conditions is what stops one bleeding into the next, and its length should be set by the half-life rather than by convenience.
Transporting a vial for a weekend away — a second dataset Replied, post #47 · Practice › Storage & stability · 7 May 2026 · 5 likes An honest declaration on Transporting a vial: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
The "under review" status pill and when a moderator applies it Replied, post #117 · Evidence › Preprints · 6 May 2026 · 26 likes The most useful convention this subcategory has: state the status, state the version, state the date you checked. Three short clauses and the citation stays honest.
Request: show the solution author in the topic list — what changed since Replied, post #33 · Meta › Feature requests · 1 May 2026 · 32 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible. I am…
Revisiting: Theoretical plates: useful number or ritual? Replied, post #3 · Analytics › HPLC & UHPLC · 17 Apr 2026 · 32 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
List price versus negotiated price versus what you pay Replied, post #110 · Access › Pricing · 17 Apr 2026 · 13 likes Larger orders shift risk as well as price, because more of your material then comes from one lot. Same conclusion as the reply above, reached differently, which is…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #96 · Practice › Storage & stability · 10 Apr 2026 · 1 like Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I keep a log of…
Journal club: LEADER as the historical anchor Replied, post #58 · Evidence › Journal club · 10 Apr 2026 · 30 likes I read post #57 twice before replying, because I had assumed the opposite. Offering a way to settle LEADER rather than another opinion about it. Two measurements, taken…
Spike-and-recover accuracy for a peptide assay Replied, post #47 · Analytics › Method validation · 8 Apr 2026 · 4 likes Agreed on all of that, and I have nothing to add to it.
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #88 · Sourcing › Vendor reports · 31 Mar 2026 · 7 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. I looked this up rather…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #17 · Evidence › Journal club · 29 Mar 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #74 · Practice › Interactions · 25 Mar 2026 · 4 likes This follows post #71 rather than contradicting it. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric…
[2026 update] What a purity-only report leaves out Replied, post #65 · Sourcing › Independent verification · 24 Mar 2026 · 1 like Two sentences on purity-only and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
Search filters: what is missing Replied, post #39 · Meta › Site feedback · 24 Mar 2026 · 11 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
Grapefruit: why this class is not the class that cares Replied, post #70 · Practice › Interactions · 23 Mar 2026 · 12 likes Building on post #69 rather than restating it. The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been…
Second pass at: When your prescriber and the evidence disagree Replied, post #3 · Clinical › Prescriber conversations · 22 Mar 2026 · 0 likes Prescriber is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Second pass at: Fasting versus non-fasting and which tests care Replied, post #19 · Clinical › Bloodwork · 15 Mar 2026 · 10 likes Post #16 and I disagree about the size of the effect, not about the direction. On Fasting versus non-fasting: the maintained page in the documentation commons covers…
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #9 · Compounds › Oral incretins · 14 Mar 2026 · 13 likes The practical argument for an oral is adherence, and the published adherence data is less flattering than the argument. Daily dosing with fasting requirements is not…
Cost per delivered dose, which is the number that matters Replied, post #56 · Access › Pricing · 11 Mar 2026 · 26 likes Where somebody posts a comparison, the useful version states the date, the region and what was included.
Pre-registering a personal experiment, seriously — a second dataset Replied, post #40 · Research Methods › N-of-1 designs · 7 Mar 2026 · 21 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
The lowest dose that does anything: is that a real question? Replied, post #61 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes Two things can be true about lowest dose at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #110 · Clinical › Special populations · 25 Feb 2026 · 14 likes Post #108 and I disagree about the size of the effect, not about the direction. Older adults is a good example of a question where the honest answer is boring and the…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #15 · Research Methods › N-of-1 designs · 25 Feb 2026 · 2 likes Reporting the whole series rather than the interesting segment is the discipline that makes personal data worth reading. Selective reporting is the default without…
Measurement error in a self-reported exposure Replied, post #7 · Evidence › Study critique · 21 Feb 2026 · 0 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. Trying to state the measurement error position in a way that someone who disagrees…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #8 · Sourcing › Red flags · 20 Feb 2026 · 31 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.…
How to ask about something you suspect is a bad idea Replied, post #57 · Start Here › How to Ask · 20 Feb 2026 · 11 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Reading SURMOUNT-1 without the press release — one year on Replied, post #49 · Compounds › Tirzepatide · 20 Feb 2026 · 1 like Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
Mass error in ppm: the arithmetic and the caveat Replied, post #116 · Analytics › Mass spectrometry · 15 Feb 2026 · 5 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #40 · Outcomes › Progress reports · 12 Feb 2026 · 8 likes Trying to state the Seven-day rolling position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
Run-in periods and the population they select Replied, post #64 · Evidence › Trials · 10 Feb 2026 · 4 likes Filing a mild objection to the consensus on run-in periods. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Pharmacy supply in the UK and the questions you will be asked Replied, post #24 · Regional › UK & Ireland · 29 Jan 2026 · 0 likes I would call the community position on pharmacy supply likely rather than established, and I would be comfortable defending that hedge.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #99 · Practice › Interactions · 28 Jan 2026 · 0 likes The practical version of Warfarin and altered intake is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #3 · Compounds › Other compounds · 16 Jan 2026 · 4 likes The opening post describes the usual case. This is about the unusual one. Fragment compounds — where the material is part of a larger natural protein — should be…
Where impurities in solid-phase peptide synthesis come from Replied, post #32 · Analytics › Impurities & related substances · 5 Jan 2026 · 1 like Reporting thresholds matter: below a stated threshold, peaks are usually not reported at all. A clean-looking table may reflect a high threshold rather than a clean…
What "verified" means on our vendor pages, stated narrowly Replied, post #31 · Sourcing › Vendor reports · 3 Jan 2026 · 5 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
The headache that turns out to be dehydration Replied, post #95 · Nutrition & Training › Hydration & electrolytes · 14 Dec 2025 · 14 likes Post #94 is the version of this I will quote in future. One addition. Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence…
Liver enzymes drifting down and what that usually means Replied, post #36 · Clinical › Bloodwork · 13 Dec 2025 · 0 likes Before the thread moves on from liver enzymes drifting — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #13 · Sourcing › Red flags · 12 Dec 2025 · 31 likes On supplier, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #2 · Outcomes › Body composition · 11 Dec 2025 · 0 likes Where I part company with the opening post, and it is a narrow parting. Bone mineral density changes with substantial weight loss are measurable and slow, and are one…
Robustness: the parameters worth deliberately varying Replied, post #51 · Analytics › Method validation · 8 Dec 2025 · 5 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways. Anyone who has looked at this…
What I would record differently if I started again — the long version Replied, post #17 · Outcomes › Progress reports · 21 Nov 2025 · 9 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
Angle of injection and whether 90 degrees is always right Replied, post #53 · Practice › Administration · 20 Nov 2025 · 12 likes What I can speak to on angle of injection is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Documentation that materially improves an appeal's chances Replied, post #57 · Access › Insurance & coverage · 9 Nov 2025 · 2 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
EMA product information as a primary source Replied, post #35 · Regional › European Union · 5 Nov 2025 · 2 likes Answering the question post #31 raises rather than the one it answers. EMA product information is well covered in the tag pages, and the older discussions are better…
Revisiting: German, French and Dutch differences, compared Replied, post #94 · Regional › European Union · 30 Oct 2025 · 0 likes Taking post #93 at face value and following it one step further. Two sentences on German and then I will stop, because the rest is speculation and the thread is better…
Specification in the result column: why that is a meaningful error Replied, post #65 · Analytics › COA interpretation · 29 Oct 2025 · 14 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
A 40-week log with the measurement method stated Replied, post #82 · Outcomes › Progress reports · 27 Oct 2025 · 0 likes Weighing daily and reporting weekly is a better protocol than weighing weekly, because it separates the measurement frequency from the reporting frequency.
History of disordered eating and why it changes the conversation Replied, post #19 · Clinical › Special populations · 25 Oct 2025 · 1 like Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating. Not a strong opinion,…
Amylin receptor signalling and satiety Replied, post #7 · Pharmacology › Receptor biology · 22 Oct 2025 · 24 likes Second this, and I would have said it less carefully.
Coming back to: Why quantitation is the hard part, not detection Replied, post #80 · Analytics › Home & field testing · 17 Oct 2025 · 20 likes Picking up post #77: that is the part I would want checked first. Adding a null result on quantitation. I looked, carefully, and found nothing, and null results deserve…
A parcel that arrived warm: a decision process, not a verdict Replied, post #80 · Practice › Storage & stability · 12 Oct 2025 · 4 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #85 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 0 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #60 · Practice › Dosing & titration · 24 Sep 2025 · 8 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Temperature loggers worth the money — the long version Replied, post #39 · Devices › Cold chain · 12 Sep 2025 · 7 likes On post #37 — agreed on the reasoning, with one qualification. Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #80 · Practice › Side effects · 8 Sep 2025 · 4 likes Worth separating two things that post #78 runs together. Fatigue has a well-known answer and a correct answer, and the interesting work is establishing that they are…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #95 · Practice › Reconstitution · 28 Jul 2025 · 7 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #26 · Compounds › Secretagogues & GH axis · 18 Jul 2025 · 18 likes One caution on reading a rodent study: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
[2026 update] Reverting an edit that had no revision note Started this topic · Meta › Wiki maintenance · 16 Jul 2025 · 12 likes Reverting an edit that had no revision note — setting out what I have, and where I think it stops being reliable. Collecting what is known about Reverting an edit in…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #31 · Practice › Dosing & titration · 15 Jul 2025 · 4 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
What this community means by "a source", in practical terms Replied, post #35 · Start Here › Welcome · 15 Jul 2025 · 10 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
A field-by-field walk through a certificate of analysis Replied, post #17 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes.
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #67 · Sourcing › Independent verification · 21 Jun 2025 · 1 like The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. A guess, clearly labelled as one.
Follow-up: Tracking intake honestly when appetite is absent Replied, post #64 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 28 likes Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than protein. I keep a log of this specifically because memory is…
DXA precision and the least significant change for lean mass — the long version Replied, post #73 · Outcomes › Body composition · 21 May 2025 · 0 likes Air displacement plethysmography and hydrostatic weighing have their own precision limits and their own protocol sensitivities. None of these are exact.
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #53 · Compounds › Retatrutide · 20 May 2025 · 11 likes Adding what did not work for me on Triple agonism, since the failures never get written up and they are half the useful information.
DXA precision and the least significant change for lean mass — the long version Replied, post #37 · Outcomes › Body composition · 13 May 2025 · 3 likes Nothing to add, except that this is the answer I would give if asked.
The C-cell question: rodent findings and their human context Replied, post #11 · Compounds › Semaglutide · 26 Apr 2025 · 1 like Where I part company with post #9, and it is a narrow parting. The STEP programme populations were selected: enrollment criteria required baseline body mass index over…
Follow-up: Documentation that appears only after payment Replied, post #14 · Sourcing › Red flags · 22 Apr 2025 · 19 likes This is the sort of exchange that makes the archive worth searching.
Coming back to: Cross-border purchase rules within the EU Replied, post #3 · Regional › European Union · 21 Apr 2025 · 2 likes Answering the question the opening post raises rather than the one it answers. Adding a reference point for Cross-border purchase rules within. Mine is a single case,…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #22 · Clinical › Comorbidities · 19 Apr 2025 · 9 likes Post #19 is the version of this I will quote in future. One addition. Where two conditions pull in opposite directions, that is a clinical judgement rather than a…
Reaching a dose and staying there for a year: a longitudinal note Replied, post #2 · Practice › Dosing & titration · 18 Apr 2025 · 19 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Titrating on tolerability rather than on the calendar:…
Retatrutide dose escalation in the published trials Replied, post #138 · Compounds › Retatrutide · 16 Apr 2025 · 15 likes Post #136 and I disagree about the size of the effect, not about the direction. On analysis: a chromatographic purity figure for an investigational compound is harder…
Follow-up: Requesting a page: what makes a good request Replied, post #22 · Documentation › Wiki requests · 16 Apr 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #53 · Compounds › Tirzepatide · 3 Apr 2025 · 0 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
Foaming during reconstitution and whether it matters Replied, post #8 · Practice › Reconstitution · 2 Apr 2025 · 0 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.…
Certificates issued by the seller versus by a laboratory Replied, post #22 · Analytics › COA interpretation · 29 Mar 2025 · 1 like Worth separating two things that post #20 runs together. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #6 · Compounds › Retatrutide · 19 Mar 2025 · 2 likes My experience of Retatrutide mass and identity contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience…
Fibre intake when total intake falls, and the constipation link Replied, post #36 · Nutrition & Training › Protein & intake · 5 Mar 2025 · 8 likes I had written a reply contradicting post #32 and deleted it. Here is what survived. Fibre intake is one of those subjects where the general answer and the answer for a…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #14 · Meta › Wiki maintenance · 3 Mar 2025 · 1 like Question for the editors: what is the standard for adding a citation to a claim that is community practice rather than published? At the moment those sentences are…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #20 · Compounds › Tirzepatide · 2 Mar 2025 · 19 likes Useful. I have added it to my own notes with the date on it.
Biased agonism: a real phenomenon, an over-used explanation Replied, post #27 · Pharmacology › Receptor biology · 1 Mar 2025 · 13 likes Biased agonism has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #19 · Compounds › Repair & healing peptides · 1 Mar 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #16 · Clinical › Comorbidities · 17 Feb 2025 · 4 likes Post #15 answers the question as asked. The question underneath it is different. Thyroid history and the C-cell finding is the clearest documented contraindication in…
Validating a method you did not develop — does this still hold? Replied, post #3 · Analytics › Method validation · 11 Feb 2025 · 9 likes Worth separating two things that the opening post runs together. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately…
When "no data" is the complete and final answer Replied, post #82 · Compounds › Other compounds · 2 Feb 2025 · 32 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #43 · Compounds › Semaglutide · 29 Jan 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
How compounding permissions changed when supply normalised Replied, post #12 · Sourcing › Regulatory · 25 Jan 2025 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
What changed in 2026, by region Replied, post #45 · Access › International · 28 Dec 2024 · 29 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them. A single…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #96 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #131 · Clinical › Prescriber conversations · 25 Dec 2024 · 12 likes Prescribers reading this subcategory consistently say the most difficult consultations are the ones where information is withheld rather than the ones with difficult…
Ipamorelin selectivity claims and where they came from Replied, post #2 · Compounds › Secretagogues & GH axis · 20 Dec 2024 · 20 likes Nothing to add on the substance. Thank you for taking the question at face value.
Follow-up: Dead volume across syringe and needle combinations Replied, post #84 · Devices › Syringes & needles · 18 Dec 2024 · 9 likes Building on post #81 rather than restating it. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #62 · Evidence › Journal club · 16 Dec 2024 · 3 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #40 · Clinical › Special populations · 8 Dec 2024 · 24 likes The documentation on Athletes in weight-category sports is better than this thread and I say that as someone who has posted in the thread.
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #118 · Analytics › COA interpretation · 15 Nov 2024 · 7 likes Building on post #116 rather than restating it. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18…
Time to steady state after a dose increase Replied, post #72 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than efficacy. A loading dose would reach steady state faster and would…
Follow-up: Dead volume across syringe and needle combinations Replied, post #58 · Devices › Syringes & needles · 31 Oct 2024 · 9 likes Answering the question post #54 raises rather than the one it answers. Coring the stopper is a real phenomenon with repeated entries at the same point and blunt…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #109 · Clinical › Comorbidities · 26 Oct 2024 · 1 like Post #105 describes the usual case. This is about the unusual one. Where somebody is on several medicines, the interaction question and the comorbidity question are…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #100 · Access › Shortages · 12 Oct 2024 · 21 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated.
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #67 · Evidence › Journal club · 8 Oct 2024 · 5 likes A request rather than an answer: could whoever has the primary source for SURPASS-2 post it? I have seen the claim three times this month and each version had lost a…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #5 · Evidence › Journal club · 8 Oct 2024 · 31 likes The opening post describes the usual case. This is about the unusual one. Reading order that works for these sessions: registry entry, methods, baseline table, primary…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #35 · Sourcing › Independent verification · 4 Sep 2024 · 0 likes I read post #31 twice before replying, because I had assumed the opposite. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #5 · Practice › Administration · 2 Sep 2024 · 11 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. The most useful reply I ever got about site rotation scheme was a request to…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #23 · Evidence › Journal club · 22 Aug 2024 · 0 likes Building on post #20 rather than restating it. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #64 · Compounds › Retatrutide · 20 Jul 2024 · 4 likes Nothing to add on the substance. Thank you for taking the question at face value.
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #17 · Safety › Contraindications · 19 Jul 2024 · 2 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Oral contraceptives and delayed emptying: what the data shows Replied, post #31 · Practice › Interactions · 11 Jul 2024 · 8 likes Useful. I have added it to my own notes with the date on it.
Cold packs, phase-change material, and what survives ten days Replied, post #51 · Sourcing › Logistics · 28 Jun 2024 · 17 likes Declared contents and declared value are the two fields most likely to cause a query, and accuracy in both is the only strategy that survives. I have left out the parts…